PBE Crosses Critical Technical Indicator Thursday, April 30, 3:49 PM ET, by Market News Video Staff In trading on Thursday, shares of the PowerShares Dynamic Biotechnology & Genome Portfolio ETF (PBE) ...
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on September 14, Bruker Corp's Director, Joerg C. Laukien, invested $1,300,000.00 into 100,000 shares of BRKR, for a cost per share of $13.00. Bargain hunters tend to pay particular attention to insider buys like this one, because presumably the only reason an insider would take their hard-earned cash and use it to buy stock of their company in the open market, is that they expect to make money.
In trading on Thursday, bargain hunters could buy shares of Bruker Corp (NASDAQ:BRKR) and achieve a cost basis 1.4% cheaper than Laukien, with shares changing hands as low as $12.82 per share. Bruker Corp shares are currently trading off about 4% on the day. The chart below shows the one year performance of BRKR shares, versus its 200 day moving average:
Looking at the chart above, BRKR's low point in its 52 week range is $9.91 per share, with $17.10 as the 52 week high point — that compares with a last trade of $12.83. By comparison, below is a table showing the prices at which insider buying was recorded over the last six months:
This Article's Word Cloud:AccountBRKRBrukerCorpDefinitionDirectorETFsImportanceIndividualInsiderJoergLaukienPortfolioPriceShareSpecialThursdayValueWhataboutbargainbelowbuyingchangingchartcostearnedexpecthuntersinsiderlastmakesmanyonlyopenotherpointreasonreasonssharesharesstockthattheirthistradingweekwhatwhichwith
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.